Cargando…

The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk

BACKGROUND: The cardiovascular risk models and subclinical atherosclerotic indicators are both recommended for cardiovascular risk stratification. The accordance between the incidence of subclinical atherosclerosis and subjects with low and moderate cardiovascular risk is unclear. HYPOTHESIS: Subjec...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhang, Yinghua, Xiao, Keling, Si, Jin, Zhang, Haoyu, Sun, Lijie, Miao, Zupei, Zhao, Ting, Sun, Jinghao, Sun, Xipeng, Liu, Zhi, Gao, Jing, Zhao, Jing, Chu, Xi, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577528/
https://www.ncbi.nlm.nih.gov/pubmed/37522647
http://dx.doi.org/10.1002/clc.24087
_version_ 1785121344399081472
author Li, Yan
Zhang, Yinghua
Xiao, Keling
Si, Jin
Zhang, Haoyu
Sun, Lijie
Miao, Zupei
Zhao, Ting
Sun, Jinghao
Sun, Xipeng
Liu, Zhi
Gao, Jing
Zhao, Jing
Chu, Xi
Li, Jing
author_facet Li, Yan
Zhang, Yinghua
Xiao, Keling
Si, Jin
Zhang, Haoyu
Sun, Lijie
Miao, Zupei
Zhao, Ting
Sun, Jinghao
Sun, Xipeng
Liu, Zhi
Gao, Jing
Zhao, Jing
Chu, Xi
Li, Jing
author_sort Li, Yan
collection PubMed
description BACKGROUND: The cardiovascular risk models and subclinical atherosclerotic indicators are both recommended for cardiovascular risk stratification. The accordance between the incidence of subclinical atherosclerosis and subjects with low and moderate cardiovascular risk is unclear. HYPOTHESIS: Subjects with low and moderate cardiovascular risk have a lower incidence of subclinical atherosclerosis compared with subjects with high risk. METHODS: Brachial‐ankle pulse wave velocity (BaPWV) and brachial flow‐mediated dilation (BFMD) were measured in 421 subjects without a history of atherosclerotic cardiovascular disease (ASCVD) from October 2016 to January 2020. All subjects were classified into low, moderate, and high risk based on Framingham and China‐par risk models respectively. RESULTS: Mean age was 57.05 ± 9.35 years and 248 (58.9%) were male. In subjects with low, moderate, and high risk assessed by Framingham and China‐par risk models, the percentage of abnormal BaPWV ( > 1400 cm/s) was 42.9%, 70.1%, 85.7%, and 40.4%, 71.4%, 89.7%, respectively. Meanwhile, the percentage of abnormal BFMD ( ≤ 7%) was 43.8%, 68.5%, 77.3%, and 44.9%,72.1%, and 76.6%. According to Framingham‐based high‐risk categories, positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for BaPWV abnormality were 85.7%, 39.4%, 36.1%, and 87.5%, respectively. For BFMD abnormality, the values were 77.3%, 40.1%, 34.1%, and 81.8%, respectively. According to China‐par high‐risk categories, the values for BaPWV abnormality were 89.7%, 43.8%, 45.6%, and 89.0%, respectively. For BFMD abnormality, the values were 76.6%, 41.3%, 40.7%, and 77%, respectively. In multivariate analysis, age and blood pressure were the independent predictors for subclinical atherosclerosis in subjects with low‐moderate risk. CONCLUSIONS: More than one‐half of subjects with low and moderate risk already have detectable subclinical atherosclerosis, indicating higher cardiovascular risk beyond the traditional stratification.
format Online
Article
Text
id pubmed-10577528
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105775282023-10-17 The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk Li, Yan Zhang, Yinghua Xiao, Keling Si, Jin Zhang, Haoyu Sun, Lijie Miao, Zupei Zhao, Ting Sun, Jinghao Sun, Xipeng Liu, Zhi Gao, Jing Zhao, Jing Chu, Xi Li, Jing Clin Cardiol Clinical Trial Result BACKGROUND: The cardiovascular risk models and subclinical atherosclerotic indicators are both recommended for cardiovascular risk stratification. The accordance between the incidence of subclinical atherosclerosis and subjects with low and moderate cardiovascular risk is unclear. HYPOTHESIS: Subjects with low and moderate cardiovascular risk have a lower incidence of subclinical atherosclerosis compared with subjects with high risk. METHODS: Brachial‐ankle pulse wave velocity (BaPWV) and brachial flow‐mediated dilation (BFMD) were measured in 421 subjects without a history of atherosclerotic cardiovascular disease (ASCVD) from October 2016 to January 2020. All subjects were classified into low, moderate, and high risk based on Framingham and China‐par risk models respectively. RESULTS: Mean age was 57.05 ± 9.35 years and 248 (58.9%) were male. In subjects with low, moderate, and high risk assessed by Framingham and China‐par risk models, the percentage of abnormal BaPWV ( > 1400 cm/s) was 42.9%, 70.1%, 85.7%, and 40.4%, 71.4%, 89.7%, respectively. Meanwhile, the percentage of abnormal BFMD ( ≤ 7%) was 43.8%, 68.5%, 77.3%, and 44.9%,72.1%, and 76.6%. According to Framingham‐based high‐risk categories, positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for BaPWV abnormality were 85.7%, 39.4%, 36.1%, and 87.5%, respectively. For BFMD abnormality, the values were 77.3%, 40.1%, 34.1%, and 81.8%, respectively. According to China‐par high‐risk categories, the values for BaPWV abnormality were 89.7%, 43.8%, 45.6%, and 89.0%, respectively. For BFMD abnormality, the values were 76.6%, 41.3%, 40.7%, and 77%, respectively. In multivariate analysis, age and blood pressure were the independent predictors for subclinical atherosclerosis in subjects with low‐moderate risk. CONCLUSIONS: More than one‐half of subjects with low and moderate risk already have detectable subclinical atherosclerosis, indicating higher cardiovascular risk beyond the traditional stratification. John Wiley and Sons Inc. 2023-07-31 /pmc/articles/PMC10577528/ /pubmed/37522647 http://dx.doi.org/10.1002/clc.24087 Text en © 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Trial Result
Li, Yan
Zhang, Yinghua
Xiao, Keling
Si, Jin
Zhang, Haoyu
Sun, Lijie
Miao, Zupei
Zhao, Ting
Sun, Jinghao
Sun, Xipeng
Liu, Zhi
Gao, Jing
Zhao, Jing
Chu, Xi
Li, Jing
The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
title The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
title_full The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
title_fullStr The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
title_full_unstemmed The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
title_short The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
title_sort incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
topic Clinical Trial Result
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577528/
https://www.ncbi.nlm.nih.gov/pubmed/37522647
http://dx.doi.org/10.1002/clc.24087
work_keys_str_mv AT liyan theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhangyinghua theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT xiaokeling theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sijin theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhanghaoyu theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sunlijie theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT miaozupei theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhaoting theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sunjinghao theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sunxipeng theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT liuzhi theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT gaojing theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhaojing theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT chuxi theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT lijing theincidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT liyan incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhangyinghua incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT xiaokeling incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sijin incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhanghaoyu incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sunlijie incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT miaozupei incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhaoting incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sunjinghao incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT sunxipeng incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT liuzhi incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT gaojing incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT zhaojing incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT chuxi incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk
AT lijing incidenceofsubclinicalatherosclerosisinsubjectswithlowandmoderatecardiovascularrisk